Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2004 Aug 31;91(5):822-8.
doi: 10.1038/sj.bjc.6602012.

Fatigue and cancer: causes, prevalence and treatment approaches

L I Wagner  1 , D Cella
Affiliations
Review

Fatigue and cancer: causes, prevalence and treatment approaches

L I Wagner et al. Br J Cancer. .

Abstract

Fatigue is the most prevalent cancer-related symptom and has a significant adverse impact on patients' functional ability and quality of life. Hypotheses regarding the aetiology of cancer-related fatigue are discussed, and clinical practice guidelines for the evaluation and management of oncology patients with fatigue are reviewed. Both nonpharmacologic and pharmacologic strategies for the management of fatigue are summarised.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Causes of fatigue (Atkinson et al, 2002; Cella et al, 1998; Portenoy and Itri, 1999).
See this image and copyright information in PMC

References

    1. Atkinson A, Barsevick A, Cella D, Cimprich B, Cleeland C, Donnelly J, Eisenberg MA, Escalante C, Hinds P, Jacobsen PB, Kaldor P, Knight SJ, Peterman A, Piper BF, Rugo H, Sabbatini P, Stahl C, the National Comprehensive Cancer Network (2000) NCCN Practice Guidelines for Cancer-Related Fatigue. Oncology 14: 151–161 - PubMed
    1. Barsevick AM, Dudley W, Beck S, Sweeney C, Whitmer K, Nail L (2004) A randomized clinical trial of energy conservation for patients with cancer-related fatigue. Cancer 100: 1302–1310 - PubMed
    1. Bower JE, Ganz PA, Aziz N, Fahey JL, Cole SW (2003) T-Cell homeostasis in breast cancer survivors with persistent fatigue. J Natl Cancer Inst 15: 1165–1168 - PubMed
    1. Broeckel JA, Jacobsen PB, Horton J, Balducci L, Lyman GH (1998) Characteristics and correlates of fatigue after adjuvant chemotherapy for breast cancer. J Clin Oncol 16: 1689–1696 - PubMed
    1. Bruera E, Chadwick S, Brenneis C, Hanson J, MacDonald RN (1987) Methylphenidate associated with narcotics for the treatment of cancer pain. Cancer Treat Rep 71: 67–70 - PubMed